Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
72nd Medical Group, Tinker Air Force Base
With
brain treatment center; MacDill AFB
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Have diagnosis of combat-related PTSD by DSM-V criteria, diagnosed via clinical interview by psychologist or psychiatrist (note: combat pilots of remotely piloted aircraft are included)
2. PCL-M score \> 45
3. Age between 18 and 55 years (at day of informed consent)
4. Willing and able to adhere to the treatment schedule and all required study visits.
5. Must be clinically stable for at least 30 days on or off any PTSD medication before the trial treatment
You may not be if
1. Individuals diagnosed by the Investigator with the following conditions (current unless otherwise stated):
* History of open skull traumatic brain injury
* History of clinically significant seizure disorder
2. Individuals with a clinically defined neurological disorder including, but not limited to:
* Any condition likely to be associated with increased intracranial pressure
* Space occupying brain lesion
* History of cerebrovascular accident
* Cerebral aneurysm
3. Abnormalities that indicate risk of seizure, i.e., focal or general slowing or spikes during EEG recording
4. Any type of rTMS treatment within 3 months prior to the screening visit
5. Currently under antipsychotic medication treatment
6. Intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants, stents, or electrodes) or any other metal object within or near the head, excluding the mouth, which cannot be safely removed
7. Clinically significant abnormality or clinically significant unstable medical condition that in the Investigator's judgment might pose a potential safety risk to the subject or limit interpretation of the trial results
8. Clinically significant medical illness, including any uncontrolled thyroid disorders, hepatic, cardiac, pulmonary and renal malfunctioning
9. Any condition which in the judgment of the investigator would prevent the subject from completion of the study
10. Inability to acquire a clinically satisfactory EEG/ECG on a routine basis
11. Grossly abnormal electrolyte or cell blood count panels suggestive of other pathology at study initiation
12. Pregnant or breastfeeding women
Clareo Health | To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder
